StartUps
– According to IMS data Xeloda made by Genentech, had $754 million in US sales in 2013. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA)...
Hi, what are you looking for?
– According to IMS data Xeloda made by Genentech, had $754 million in US sales in 2013. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA)...
– Ontario court exonerates Shnaider and Shyfrin; Midland awarded millions of dollars in damages. – – Canadian Businessman Alex Shnaider, Eduard Shyfrin and Midland...
– Teva has 180 days of marketing exclusivity for generic Evista, which had 2013 US sales of $824 million. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)...
– The first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. –...
– Autonomous cluster flight of multiple satellites, an electric passenger aircraft, drones and anti-tank missiles are some of the projects that were presented at a...
– Technion researchers discovered rare chemical materials that demonstrate an ability to bond a positively charged metal (+) to a positively charged non-metal (+) – –...
– Tel Aviv University targets drug-resistant ovarian tumors with nanotechnology. Ovarian cancer accounts for more deaths of American women than any other cancer of...
– RedHill Biopharma and Salix Pharmaceuticals Announce Worldwide Exclusive License Agreement for RedHill’s RHB-106 Encapsulated Bowel Preparation. Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) and RedHill Biopharma...
– Frutarom Strengthens its Position as a Leading Global Player in Healthy and Natural Taste Solutions. This is the fourth acquisition completed last year. –...
– – A scarce Golda Meir handwritten postcard showing the Nile River in Cairo will be auctioned on February 27 by Nate D. Sanders...